EPCAM and ovarian neoplasm: In parallel, the absolute cell number of viable EpCAM (CD326)-positive ovarian tumor cells is reduced compared to day 0 (Figure 5E), which underline the observation that Vδ2 T-cell cytotoxicity is not influenced by galectin-3 (Figure 4).